A multicenter, double-blind, placebo-controlled study conducted over 2 years enrolled 303 patients ages 18 to 55 years with recent CIS suggestive of MS. Disease activity was observed in a smaller ...

January 30, 2010 — Tears may one day replace cerebrospinal fluid in diagnosing multiple sclerosis, report researchers. The new isoelectric focusing technique detects oligoclonal bands in eye fluid and ...

As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...

Optic nerve involvement is common among patients presenting with CIS of MS. Adding the optic nerve as a fifth site for dissemination in space fulfillment increases the sensitivity, decreases the ...

Tysabri (natalizumab) is a prescription drug used for relapsing-remitting multiple sclerosis (MS), active secondary progressive MS, and clinically isolated syndrome. Tysabri does not come as a generic ...

Radiologically isolated syndrome (RIS) involves MS-like lesions on MRI without clinical symptoms, with a significant risk of progression to MS. Updated 2023 RIS criteria improve diagnostic accuracy, ...

Copaxone (glatiramer) is a prescription drug that’s used in adults to treat certain types of multiple sclerosis and clinically isolated syndrome. Copaxone comes as a liquid solution that you’ll inject ...

A new study found that, for people with early MS, a diet high in ultra-processed foods appeared to worsen disease activity. People with early multiple sclerosis who ate more ultra-processed foods had ...

People with early multiple sclerosis who ate more ultra-processed foods had more relapses and brain lesions than people who ate very little of these foods. These foods did not increase participants' ...